These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20570876)

  • 1. Predicting cardiovascular risk. How many are missed?
    Lewis LS
    BMJ; 2010 Jun; 340():c3329. PubMed ID: 20570876
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting cardiovascular risk. Using risk scores with patients.
    Parkes G
    BMJ; 2010 Jun; 340():c3327. PubMed ID: 20570875
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving the accuracy of predicting cardiovascular risk.
    Scott I
    BMJ; 2010 May; 340():c2334. PubMed ID: 20466792
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating cardiovascular risk assessment for asymptomatic people.
    Scott IA
    BMJ; 2009 Jan; 338():a2844. PubMed ID: 19124547
    [No Abstract]   [Full Text] [Related]  

  • 5. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors.
    Milne R; Gamble G; Whitlock G; Jackson R
    N Z Med J; 2003 Nov; 116(1185):U663. PubMed ID: 14615805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality.
    De Bacquer D; De Backer G
    Int J Cardiol; 2010 Sep; 143(3):385-90. PubMed ID: 19386372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk in cardiovascular disease. Joint British societies recommend their computer program for risk calculations.
    Durrington PN
    BMJ; 2000 Jul; 321(7254):174-5. PubMed ID: 10950540
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of ambulatory blood pressure in older adults: the Dublin outcome study.
    Burr ML; Dolan E; O'Brien EW; O'Brien ET; McCormack P
    Age Ageing; 2008 Mar; 37(2):201-6. PubMed ID: 18349014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simplifying cardiovascular risk estimation using resting heart rate.
    Cooney MT; Vartiainen E; Laatikainen T; Joulevi A; Dudina A; Graham I
    Eur Heart J; 2010 Sep; 31(17):2141-7. PubMed ID: 20657020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Your Heart Forecast': a new approach for describing and communicating cardiovascular risk?
    Wells S; Kerr A; Eadie S; Wiltshire C; Jackson R
    Heart; 2010 May; 96(9):708-13. PubMed ID: 20424153
    [No Abstract]   [Full Text] [Related]  

  • 12. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 13. What type of exercise prevents cardiovascular disease in postmenopausal women?
    Rivet C
    CMAJ; 2003 Feb; 168(3):314. PubMed ID: 12566338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiovascular risk profile and anti-hypertensive treatment].
    Olsen MH; Sehestedt T; Prescott E
    Ugeskr Laeger; 2009 Jun; 171(24):2008-11. PubMed ID: 19523363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAFLD and cardiovascular risk: direct evidence for the tale of two ages.
    Lonardo A; Loria P
    Am J Gastroenterol; 2009 Jul; 104(7):1851-2. PubMed ID: 19574981
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating risk for cardiovascular diseases--vain or value? How do different cardiovascular risk scores act in real life.
    Ketola E; Laatikainen T; Vartiainen E
    Eur J Public Health; 2010 Feb; 20(1):107-12. PubMed ID: 19482991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular Risk Assessment: preliminary results].
    Palmieri L; Rielli R; Demattè L; Donfrancesco C; La Terza G; De Sanctis Caiola P; Dima F; Lo Noce C; Giannelli AM; Brignoli O; Cuffari A; De Rosa M; Addis A; Laurendi G; Giampaoli S
    G Ital Cardiol (Rome); 2010 Feb; 11(2):154-61. PubMed ID: 20408480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program.
    Ridker PM; Cook N
    Circulation; 2005 Feb; 111(5):657-8. PubMed ID: 15699285
    [No Abstract]   [Full Text] [Related]  

  • 20. Should we give aspirins and statins to the elderly?
    Gray B
    J Prim Health Care; 2009 Dec; 1(4):338-9; author reply 339. PubMed ID: 20695068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.